Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study on the Clinical Efficacy of Teclistamab and TalquetamabBlood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseRecruitingNot stated2026-09-25NCT06477783

2 results · Page 1 of 1

Swipe the table sideways for more columns.

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Algemeen Ziekenhuis Maria Middelares (AZMM)GhentBelgium1
AZ DeltaRoeselareBelgium7
AZ GroeningeKortrijkBelgium9
CHR CitadelleLiègeBelgium5
CHU Ambroise ParéMonsBelgium1
CHU LiègeLiègeBelgium3
CHU UCL NamurYvoirBelgium6
EpiCURAHornuBelgium1
Grand Hôpital de CharleroiCharleroiBelgium1
ImeldaBonheidenBelgium1
Institut Jules BordetBrusselsBelgium1
Jessa ZiekenhuisHasseltBelgium13
UCL Saint LucBrusselsBelgium1
Universitair Ziekenhuis Antwerpen (UZA)EdegemBelgium1
Universitair Ziekenhuis Gent (UZ Gent)GhentBelgium1
UZ Leuven GasthuisbergLeuvenBelgium33
VitazSint-NiklaasBelgium6